文献速递垂体与肾上腺疾病

西班牙原发性醛固酮增多症基因检测:SPAIN-ALDO注册研究结果及文献综述

Genetic Testing for Primary Aldosteronism in SPAIN: Results From the SPAIN-ALDO Registry and Review of the Literature.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

基于西班牙35家三级医院SPAIN-ALDO注册研究的回顾性多中心分析,855例原发性醛固酮增多症患者中仅25例(3%)接受家族性醛固酮增多症基因检测,符合基因检测标准的57例中仅8例(14.0%)实际检测,仅1例检出FH III型(KCNJ5致病性变异)。文献综述汇总FH I型246例、II型72例、III型29例、IV型12例。

要点

  • SPAIN-ALDO注册中855例PA患者仅25例(3%)接受FH基因检测。
  • 符合基因检测标准的57例中仅8例(14.0%)实际检测,86%未评估。
  • FH仅占注册病例0.2%,但疑似病例中患病率可高达4%。

核心结论

  • FH基因检测在真实临床实践中常不充分,本队列中符合基因检测标准的患者86%未接受评估。
  • FH是PA少见病因,在SPAIN-ALDO注册中仅占0.2%,但在疑似病例中患病率可高达4%。

研究设计与样本

  • 回顾性多中心研究,纳入西班牙35家三级医院随访的PA患者(SPAIN-ALDO注册)。
  • 注册共纳入855例PA患者,其中25例(3%)接受FH基因检测,仅24例有完整结果。
  • 另进行文献系统综述,检索并汇总FH病例报告。

主要发现

  • 855例PA患者中25例(3%)接受FH基因检测,仅24例结果完整。
  • 符合PA基因检测标准者57例,其中仅8例(14.0%)接受基因检测。
  • 其余17例接受基因检测者的检测原因异质性较大。
  • 仅1例检出FH III型(KCNJ5致病性变异)。
  • 文献综述共纳入25篇报告FH I型246例、12篇报告FH II型72例、14篇报告FH III型29例、3篇报告FH IV型12例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: It is estimated that about 5% of the primary aldosteronism (PA) cases are of hereditary origin (familial hyperaldosteronism, FH). To date, 4 forms of FH have been reported. However, in general little is known about the genetic causes that lead to the development of PA. OBJECTIVE: This work aimed to determine the rate of genetic testing for FH in the SPAIN-ALDO Registry and to describe the clinical characteristics of patients with FH. In addition, a literature review of reports of FH cases was performed. METHODS: A retrospective multicenter study of PA in patients followed in 35 Spanish tertiary hospitals (SPAIN-ALDO Registry). RESULTS: Twenty-five of the 855 patients (3%) with PA included in the registry underwent genetic testing for FH, with complete results available for only 24 patients. However, we found that there were 57 patients who met the criteria for performing a genetic study of PA. Only 8 out of these 57 patients were genetically tested (14.0%), while the reasons to perform a genetic study in the remaining 17 genetically studied cases were quite heterogeneous. A positive result for FH was found in only one case for FH type III (KCNJ5 pathogenic variant). A systematic review of the literature was performed and identified a total of 25 articles reporting 246 patients with FH type I, 12 articles reporting 72 patients with FH type II, 14 articles reporting 29 cases of FH type III, and 3 articles reporting 12 patients with FH type IV. CONCLUSION: The genetic study of FH is often scarce in real-world clinical practice, as 86% of patients with criteria to undergo genetic study were not evaluated in our cohort. Nevertheless, FH is an uncommon cause of PA, representing only 0.2% of cases in the SPAIN-ALDO Registry, although its prevalence may be as high as 4% among suspected cases.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Araujo-Castro M, Ruiz-Sánchez JG, Gonzalvo C, et al. Genetic Testing for Primary Aldosteronism in SPAIN: Results From the SPAIN-ALDO Registry and Review of the Literature. J Clin Endocrinol Metab. 2025. PMID: 39058909. doi:10.1210/clinem/dgae523

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。